Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations-Reference-Cited by-同舟云学术

Collecting Duct Carcinomas Represent a Unique Tumor Entity Based on Genetic Alterations

Published:2013-10-22 Issue:10 Volume:8 Page:e78137
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Becker Frank,Junker Kerstin,Parr Martin,Hartmann Arndt,Füssel Susanne,Toma Marieta,Grobholz Rainer,Pflugmann Thomas,Wullich Bernd,Strauss Arne,Behnes Carl Ludwig,Otto Wolfgang,Stöckle Michael,Jung Volker

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Collecting duct carcinoma of the kidney;S Fleming;Histopathology,1986

2. Collecting duct carcinoma of the kidney;MA Dimopoulos;Br J Urol,1993

3. Collecting duct carcinoma of the kidney;SM Kennedy;Hum Pathol,1990

4. Collecting duct carcinoma of the kidney: a case report and review of the literature;MD Carter;J Urol,1992

5. Prospective multicenter phase II study of gemcitabine plus platinum salt for metastatic collecting duct carcinoma: results of a GETUG (Groupe d'Etudes des Tumeurs Uro-Genitales) study;S Oudard;J Urol,2007

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomic alterations and diagnosis of renal cancer;Virchows Archiv;2023-11-24

2. Collecting Duct Carcinoma of the Kidney: A Single-Center Retrospective Study of 23 Cases;Technology in Cancer Research & Treatment;2023-01

3. Neutrophil-to-Lymphocyte Ratio and Early Tumor Shrinkage as Predictive Biomarkers in Unresectable Hepatocellular Carcinoma Patients Treated With Lenvatinib, PD-1 Inhibitors, in Combination With TACE;Technology in Cancer Research & Treatment;2023-01

4. Update in collecting duct carcinoma: Current aspects of the clinical and molecular characterization of an orphan disease;Frontiers in Oncology;2022-10-04

5. A genomic mutation spectrum of collecting duct carcinoma in the Chinese population;BMC Medical Genomics;2022-01-03